Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension
- PMID: 22723323
- PMCID: PMC3431565
- DOI: 10.1210/jc.2012-1486
Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension
Abstract
Objective: Both aldosterone and cortisol can activate the mineralocorticoid receptor (MR). Polymorphisms in the MR gene have been inconsistently shown to be associated with risk of hypertension and aldosterone and cortisol levels. The purpose of this project was to investigate the association of MR gene variants with serum aldosterone and a previously identified hypertension subgroup with higher urinary free cortisol (UFC) levels (high-mode UFC) in a rigorously phenotyped Caucasian hypertensive cohort.
Materials and methods: A haplotype-based tagging single nucleotide polymorphism (htSNP) association study was conducted in the HyperPATH cohort of 570 hypertensive Caucasian subjects on a salt-controlled diet. Haplotypes generated from 74 htSNP representing the common genetic variations of the entire MR gene were analyzed by comparing high- vs. normal-mode UFC groups and the association with serum aldosterone levels.
Results: Of the observed 20 haplotype blocks, there were three main linkage disequilibrium (LD) regions with high recombination rates between adjacent regions. Overlaying gene structure on this LD map revealed that block 1-8 corresponded to exon 5-9 [ligand binding domain (LBD)], blocks 9-18 to exon 3-4 [DNA binding domain (DBD)], and block 19-20 to exon 1-2 (N-terminal domain). Haplotype association results showed that DBD-aligned LD blocks were associated with high-mode UFC status (global P values, 0.0004 to 0.05). The LBD-aligned LD blocks showed significant associations with serum aldosterone levels.
Conclusions: These findings imply that there may be differential functional importance of the DBD and LBD of the MR in the regulation of glucocorticoid and aldosterone levels in hypertensive subjects.
Figures
References
-
- Funder JW. 2010. Aldosterone and mineralocorticoid receptors in the cardiovascular system. Prog Cardiovasc Dis 52:393–400 - PubMed
-
- Mihailidou AS. 2012. Aldosterone in heart disease. Curr Hypertens Rep 14:125–129 - PubMed
-
- Joëls M, Karst H, DeRijk R, de Kloet ER. 2008. The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31:1–7 - PubMed
-
- Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP. 2000. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119–123 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL047651/HL/NHLBI NIH HHS/United States
- R01 HL47651/HL/NHLBI NIH HHS/United States
- K23 HL084236/HL/NHLBI NIH HHS/United States
- P01 DK038226/DK/NIDDK NIH HHS/United States
- M01RR00095/RR/NCRR NIH HHS/United States
- T32 HL007609/HL/NHLBI NIH HHS/United States
- M01 RR000095/RR/NCRR NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- M01 RR000064/RR/NCRR NIH HHS/United States
- 1 UL1 RR025758/RR/NCRR NIH HHS/United States
- M01RR00064/RR/NCRR NIH HHS/United States
- P50 HL055000/HL/NHLBI NIH HHS/United States
- M01 RR002635/RR/NCRR NIH HHS/United States
- P50HL055000/HL/NHLBI NIH HHS/United States
- M01RR02635/RR/NCRR NIH HHS/United States
- R01HL59424/HL/NHLBI NIH HHS/United States
- T32HL007609/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
